Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Investing Activities ₹-2,082 Cr₹-1,054 Cr₹-1,369 Cr₹-1,222 Cr₹-439 Cr

What is the latest Cash Flow from Investing Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Investing Activities ratio of MANKIND PHARMA is ₹-2,082 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Investing Activities
Mar2024₹-2,082 Cr
Mar2023₹-1,054 Cr
Mar2022₹-1,369 Cr
Mar2021₹-1,222 Cr
Mar2020₹-439 Cr

How is Cash Flow from Investing Activities of MANKIND PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2024 ₹-2,082 Cr
Negative
Mar2023 ₹-1,054 Cr
Negative
Mar2022 ₹-1,369 Cr
Negative
Mar2021 ₹-1,222 Cr
Negative
Mar2020 ₹-439 Cr -

Compare Cash Flow from Investing Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,282.7 Cr 0.9% -3.4% 37% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,518.0 Cr -0.1% -6.3% 49.2% Stock Analytics
DIVIS LABORATORIES ₹158,636.0 Cr 3.5% 0.9% 66.2% Stock Analytics
CIPLA ₹118,368.0 Cr -2.6% -3.8% 19.2% Stock Analytics
DR REDDYS LABORATORIES ₹99,671.4 Cr -4.1% -10.8% 9.5% Stock Analytics
ZYDUS LIFESCIENCES ₹95,013.6 Cr -2% -6.1% 49.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.9%

-3.4%

37%

SENSEX

-1.9%

-5%

17.5%


You may also like the below Video Courses